David A Gewirtz

23PUBLICATIONS
69CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 24, 2026
Cytostatic autophagy: an underappreciated form of autophagy and its ramifications in cancer.

|Apr 27, 2026
Sacituzumab Govitecan as an Effective Strategy for Sensitizing Chemoresistant HNSCC Cells to Senolytic Intervention.

|Mar 04, 2026
Improving Preclinical Cancer Drug Development Models to Avoid Clinical Failure.

David A Gewirtz, Beverly Teicher, Edward Greenberg

|Jul 12, 2025
Effectiveness of PROTAC BET Degraders in Combating Cisplatin Resistance in Head and Neck Cancer Cells.

Natalie Luffman, Fereshteh Ahmadinejad, Ryan M Finnegan

|Mar 04, 2025
A Critical Appraisal of the Utility of Targeting Therapy-Induced Senescence for Cancer Treatment.

Tareq Saleh, Edward F Greenberg, Anthony C Faber

|Nov 09, 2024
A BPTF Inhibitor That Interferes with the Multidrug Resistance Pump to Sensitize Murine Triple-Negative Breast Cancer Cells to Chemotherapy.

Melanie M Sinanian, Afshan Rahman, Ahmed M Elshazly

Pageof 4

Frequent Collaborators

10 joint publications

Ahmed M Elshazly

6 joint publications

Tareq Saleh

6 joint publications

Hisashi Harada

3 joint publications

Jingwen Xu